In the first of two articles, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of THC and CBD.
Eric Schneider, the managing director of AlphaRoot, a tech-enabled cannabis insurance broker, explains how cannabis cultivators can maintain their momentum in the industry.
Jessica McKeil explores the practicalities of pre-extraction protocols.
Technology Networks – Analytical Cannabis’ sister publication – spoke to the team at Delix Therapeutics' to learn how their drugs can keep the benefits of psychedelics compounds while leaving behind the trip.
Analytical Cannabis speaks to the extractors using automated solutions to boost their productivity.
Analytical Cannabis rounds up the year’s top cannabis stories, with a particular focus on research and testing.
Young told the recent Analytical Cannabis Expo Europe Online 2022 audience of the importance of stability testing and how to properly conduct shelf stability studies that are effective for a wide variety of cannabis products.
Dr. Perkins spoke with Technology Networks – the sister publication of Analytical Cannabis – to provide context on the latest research study and the next steps for the research group.
Stephen Wright breaks down the lengthy process of getting a psychedelic medicine approved in the US.